Hjem › Lupus nefritis › Colorado
Lupus nefritis kliniske forsøg i Colorado
7 studier for Lupus nefritis søger deltagere på steder i Colorado.
Byer i Colorado
Officiel studietekst (engelsk)
Study of Efficacy and Safety of LNP023 in Participants With Active Lupus Nephritis Class III-IV, +/- V
- University of Colorado Denver, Aurora
RekruttererFase 2
Alder 18 til 100 · Alle køn · Opdateret 1. okt. 2026 · NCT05268289VIBRANT: VIB4920 for Active Lupus Nephritis
- University of Colorado School of Medicine: Division of Rheumatology, Aurora
RekruttererFase 2
Alder 18 og opefter · Alle køn · Opdateret 16. sep. 2026 · NCT05201469The Pediatric Lupus Nephritis Mycophenolate Mofetil (PLUMM) Study
- Children's Hospital Colorado, Aurora
RekruttererFase 2
Alder 8 til 20 · Alle køn · Opdateret 14. sep. 2026 · NCT05538208A Study to Investigate the Safety and Preliminary Efficacy of ALLO-329, an Allogeneic CAR T-cell Therapy, in Adults With Autoimmune Disease
- University of Colorado Denver, Aurora
RekruttererFase 1
Alder 18 til 74 · Alle køn · Opdateret 10. sep. 2026 · NCT07085104A Study to Evaluate the Efficacy, Safety, and Pharmacokinetics of Obinutuzumab in Adolescents With Active Class III or IV Lupus Nephritis and the Safety and PK of Obinutuzumab in Pediatric Participants
- Children's Hospital Colorado, Anchutz Medical Campus, Aurora
RekruttererFase 2
Alder 5 til 17 · Alle køn · Opdateret 3. sep. 2026 · NCT05039619PRESERVE: LUPKYNIS in Combination With Belimumab, Obinutuzumab or Anifrolumab in Patients With Lupus Nephritis
- Western Nephrology & Metabolic Bone Disease, PC, Arvada
RekruttererFase 4
Alder 18 til 75 · Alle køn · Opdateret 3. aug. 2026 · NCT07611214A Long-Term Follow-Up Study for Participants Previously Treated With KYV-101
- University of Colorado, Denver, Denver
RekruttererObservationsstudie
Alder 18 og opefter · Alle køn · Opdateret 11. feb. 2026 · NCT07403188Fra ClinicalTrials.gov, data hentet 5. okt. 2026. Hver studie har sine egne kvalifikationskrav; studieteamet afgør, hvem der kan deltage.